Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Efficacy of Withania somnifera chemotypes NMITLI - 101R, 118R and Withaferin A against experimental visceral leishmaniasis.

Tripathi CD, Gupta R, Kushawaha PK, Mandal C, Misra Bhattacharya S, Dube A.

Parasite Immunol. 2014 Jun;36(6):253-65. doi: 10.1111/pim.12112.

2.

Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.

Tripathi CD, Kushawaha PK, Sangwan RS, Mandal C, Misra-Bhattacharya S, Dube A.

Phytomedicine. 2017 Jan 15;24:87-95. doi: 10.1016/j.phymed.2016.11.012. Epub 2016 Nov 16.

PMID:
28160866
3.

Withania somnifera chemotypes NMITLI 101R, NMITLI 118R, NMITLI 128R and withaferin A protect Mastomys coucha from Brugia malayi infection.

Kushwaha S, Soni VK, Singh PK, Bano N, Kumar A, Sangwan RS, Misra-Bhattacharya S.

Parasite Immunol. 2012 Apr;34(4):199-209. doi: 10.1111/j.1365-3024.2012.01352.x.

4.

Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice.

Kushwaha S, Roy S, Maity R, Mallick A, Soni VK, Singh PK, Chaurasiya ND, Sangwan RS, Misra-Bhattacharya S, Mandal C.

Vaccine. 2012 Feb 1;30(6):1083-93. doi: 10.1016/j.vaccine.2011.12.031. Epub 2011 Dec 17.

PMID:
22182427
5.

Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.

Gupta R, Kushawaha PK, Samant M, Jaiswal AK, Baharia RK, Dube A.

J Antimicrob Chemother. 2012 Feb;67(2):440-3. doi: 10.1093/jac/dkr485. Epub 2011 Nov 25.

PMID:
22121191
6.

Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.

Kushawaha PK, Gupta R, Sundar S, Sahasrabuddhe AA, Dube A.

J Immunol. 2011 Dec 15;187(12):6417-27. doi: 10.4049/jimmunol.1102081. Epub 2011 Nov 11.

7.

Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.

Sachdeva H, Sehgal R, Kaur S.

Parasitol Res. 2013 Jun;112(6):2269-80. doi: 10.1007/s00436-013-3387-2. Epub 2013 Mar 22.

PMID:
23519426
9.

Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.

Khare P, Jaiswal AK, Tripathi CD, Joshi S, Sundar S, Dube A.

Parasitol Res. 2014 Mar;113(3):851-62. doi: 10.1007/s00436-013-3716-5. Epub 2013 Dec 27.

PMID:
24370734
10.

Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.

Kushawaha PK, Gupta R, Tripathi CD, Sundar S, Dube A.

PLoS One. 2012;7(4):e35670. doi: 10.1371/journal.pone.0035670. Epub 2012 Apr 23.

11.

Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.

Gupta R, Kumar V, Kushawaha PK, Tripathi CP, Joshi S, Sahasrabuddhe AA, Mitra K, Sundar S, Siddiqi MI, Dube A.

PLoS One. 2014 Jan 24;9(1):e86073. doi: 10.1371/journal.pone.0086073. eCollection 2014.

12.

Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus.

Kaur S, Chauhan K, Sachdeva H.

J Med Microbiol. 2014 Oct;63(Pt 10):1328-38. doi: 10.1099/jmm.0.072694-0. Epub 2014 Jul 31.

PMID:
25082945
13.
14.

Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.

Kumari S, Samant M, Misra P, Khare P, Sisodia B, Shasany AK, Dube A.

Vaccine. 2008 Oct 23;26(45):5700-11. doi: 10.1016/j.vaccine.2008.08.021. Epub 2008 Aug 30.

PMID:
18762224
15.

A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice.

Malik F, Singh J, Khajuria A, Suri KA, Satti NK, Singh S, Kaul MK, Kumar A, Bhatia A, Qazi GN.

Life Sci. 2007 Mar 27;80(16):1525-38. Epub 2007 Jan 25.

PMID:
17336338
16.

Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.

Samant M, Gupta R, Kumari S, Misra P, Khare P, Kushawaha PK, Sahasrabuddhe AA, Dube A.

J Immunol. 2009 Jul 1;183(1):470-9. doi: 10.4049/jimmunol.0900265.

17.

115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.

Choudhury R, Das P, De T, Chakraborti T.

Immunobiology. 2013 Jan;218(1):114-26. doi: 10.1016/j.imbio.2012.02.008. Epub 2012 Feb 16.

PMID:
22440312
18.

Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.

Sachdeva H, Sehgal R, Kaur S.

Exp Parasitol. 2014 Feb;137:53-65. doi: 10.1016/j.exppara.2013.12.006. Epub 2013 Dec 25.

PMID:
24370645
19.

Alcoholic Fractions F5 and F6 from Withania somnifera Leaves Show a Potent Antileishmanial and Immunomodulatory Activities to Control Experimental Visceral Leishmaniasis.

Chandrasekaran S, Veronica J, Sundar S, Maurya R.

Front Med (Lausanne). 2017 May 12;4:55. doi: 10.3389/fmed.2017.00055. eCollection 2017.

20.

Withanolide Z, a new chlorinated withanolide from Withania somnifera.

Pramanick S, Roy A, Ghosh S, Majumder HK, Mukhopadhyay S.

Planta Med. 2008 Nov;74(14):1745-8. doi: 10.1055/s-2008-1081357. Epub 2008 Nov 5.

PMID:
18988152

Supplemental Content

Support Center